State HI
Clinical Trials in Hawaii
Hawaii is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Hawaii and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 37 actively recruiting studies with Hawaii sites out of 37 registered in total. The busiest research areas in Hawaii are Breast Cancer, Breast Carcinoma, Colorectal Carcinoma. Leading sponsors running trials in the state include National Cancer Institute (NCI), NRG Oncology, Children's Oncology Group. By stage, Hawaii trials break down as Phase 2 (11), Phase 3 (17).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Hawaii
Frequently Asked Questions — Clinical Trials in Hawaii
How many clinical trials are currently recruiting in Hawaii?
ClinicalMetric currently tracks 37 actively recruiting clinical trials with at least one location in Hawaii. The total number of registered studies—including active but not currently enrolling trials—is 37. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Hawaii?
Hawaii hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Breast Carcinoma, Colorectal Carcinoma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Hawaii serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Hawaii?
To join a clinical trial in Hawaii, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Hawaii maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Hawaii
NCT04852887 Phase 3
Recruiting
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, O...
Condition
Stage I Breast Cancer
Enrollment
1,670 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
NCT05896189 N/A
Recruiting
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Surv...
Condition
Breast Cancer
Enrollment
386 pts
Location
United States, Puerto Rico
Sponsor
NRG Oncology
NCT02523014 Phase 2
Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating ...
Condition
Intracranial Meningioma
Enrollment
124 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT04402788 Phase 2, Phase 3
Recruiting
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment ...
Condition
Extensive Stage Lung Small Cell Carcinoma
Enrollment
138 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04322318 Phase 2
Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and R...
Condition
Anaplastic Kidney Wilms Tumor
Enrollment
256 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT07018713 Phase 3
Recruiting
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preve...
Condition
Chronic Migraine
Enrollment
780 pts
Location
United States, Austria, Canada
Sponsor
Merz Therapeutics GmbH
NCT06929520 N/A
Recruiting
The Development and Evaluation of a Culturally Grounded ENDS Intervention for Ru...
Condition
E-cigarette Use
Enrollment
500 pts
Location
United States
Sponsor
University of Hawaii
NCT07321886 Phase 3
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight ...
Condition
Obesity
Enrollment
1,980 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
NCT04267848 Phase 3
Recruiting
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemoth...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
1,210 pts
Location
United States, Guam
Sponsor
National Cancer Institute (NCI
NCT06492616 Phase 3
Recruiting
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With E...
Condition
Breast Cancer
Enrollment
4,220 pts
Location
United States, Argentina, Australia
Sponsor
Stemline Therapeutics, Inc.
NCT06876714 Phase 3
Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People W...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
1,524 pts
Location
United States, Puerto Rico
Sponsor
Alliance for Clinical Trials i
NCT03851445 Phase 2, Phase 3
Recruiting
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung...
Condition
Previously Treated Non-Small Cell Lung Cancer
Enrollment
10,000 pts
Location
United States
Sponsor
SWOG Cancer Research Network
Page 2 of 2 — 37 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology